NEW YORK (GenomeWeb News) – Pharmacy benefits manager Medco Health Solutions said Monday that it has partnered with the US Food and Drug Administration to study the impact of genetic testing on the efficacy of prescription drugs.
 
The Franklin Lakes, NJ-based firm said that it would work with the FDA to jointly develop research projects, programs, and strategies in pharmacogenomics.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.